Anebulo PharmaceuticalsANEB
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 19 institutions reported holding Anebulo Pharmaceuticals Inc. (ANEB) in their 13F filings, down 2 from Q3 2025. 2 opened new positions and 4 sold out. The largest holders were 22NW, LP ($84.8M), Nantahala Capital Management, LLC ($3.1M) and Mangrove Partners Im, LLC ($2.6M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Anebulo Pharmaceuticals Inc.
- CUSIP
- 034569103
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $24K |
| Exits | 4 | $96K |
All 13F filers, Q3 2025 → Q4 2025: 187,264 shares bought and 198,306 shares sold, net −11,042 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| 22NW, LP | 35.68% | No change | 15,467,300 | $84.8M |
| Nantahala Capital Management, LLC | 0.18% | No change | 3,036,325 | $3.1M |
| Mangrove Partners Im, LLC | 0.21% | No change | 2,525,252 | $2.6M |
| Vanguard Group Inc. | 0.00% | Add +42.2% | 435,821 | $440K |
| Morgan Stanley | 0.00% | No change | 399,404 | $403K |
| Geode Capital Management, LLC | 0.00% | Reduce -7.7% | 160,760 | $162K |
| Rangeley Capital, LLC | 0.04% | Add +150.0% | 50,000 | $51K |
| Renaissance Technologies | 0.00% | Reduce -11.9% | 25,098 | $25K |
| Citadel Advisors | 0.00% | New | 24,239 | $24K |
| BlackRock, Inc. | 0.00% | Reduce -1.1% | 23,790 | $24K |
| Northern Trust Corp. | 0.00% | Reduce -9.8% | 21,994 | $22K |
| Ikarian Capital, LLC | 0.00% | Reduce -88.8% | 17,736 | $18K |
| State Street Corp. | 0.00% | No change | 12,768 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +84.6% | 3,230 | $3K |
| UBS Group AG | 0.00% | Add +960.9% | 2,334 | $2K |
| JPMorgan Chase & Co. | 0.00% | Add +5.4% | 2,253 | $2K |
| Bank of America Corp. | 0.00% | Reduce -57.1% | 382 | $386 |
| Royal Bank of Canada | 0.00% | New | 30 | $0 |
| FNY Investment Advisers, LLC | 0.00% | Add +5.3% | 100 | $0 |
"% of holder's portfolio" is ANEB's weight in each manager's 13F, not the share of Anebulo Pharmaceuticals Inc. the manager owns.